Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
2 other identifiers
interventional
126
3 countries
3
Brief Summary
People with Multiple Sclerosis (MS) often experience cognitive difficulties such as memory problems, concentration issues, and reduced processing speed. These symptoms can have a negative impact on daily functioning and overall quality of life. Previous research on cognitive rehabilitation has shown that regular training focused on memory and concentration can have positive effects on cognitive functioning, including processing speed, memory, and executive functions that support daily activities. Moreover, fMRI studies (brain scans that measure brain activity) have revealed changes in brain activation following cognitive rehabilitation. Recently, the idea has emerged that a more personalized approach could improve treatment outcomes. Specifically, researchers have identified a link between personality traits and cognitive functioning. Since every individual is different, current cognitive rehabilitation programs often fail to take these personal differences into account. In this project, the investigators aim to enhance the effectiveness of cognitive rehabilitation by focusing more closely on individual characteristics through an app-based training program. Participants will complete a 12-week app training prior to a 6-week cognitive rehabilitation program. The first app focuses on mindset training, supported by a coach. Afterwards, all participants will use a second app designed to train processing speed and memory. In addition to cognitive functioning, the investigators will also examine psychological, (neuro)biological, and social changes using questionnaires and fMRI. This research may provide valuable insights into how cognitive functioning and quality of life in people with MS can be improved. This study is funded by the National MS Fund and is a collaboration between several institutions: the Department of Health, Medical and Neuropsychology at Leiden University (The Netherlands), the University at Buffalo (USA), and Reha Rheinfelden (Switzerland).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable multiple-sclerosis
Started Nov 2025
Longer than P75 for not_applicable multiple-sclerosis
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2025
CompletedFirst Submitted
Initial submission to the registry
November 3, 2025
CompletedFirst Posted
Study publicly available on registry
November 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
November 10, 2025
November 1, 2025
3.2 years
November 3, 2025
November 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Objective cognitive changes between baseline and post-intervention
Objective cognitive changes between baseline and post intervention will be assessed using the Symbol Digit Modalities Test assessing information processing speed.
Between baseline and week 18.
Subjective cognitive changes between baseline and post-intervention
Subjective cognitive changes between baseline and post intervention will be assessed using the Multiple Sclerosis Instrumental Activities of Daily Living Questionnaire.
Between baseline and week 18.
Secondary Outcomes (12)
Changes between baseline and week 18 on meaning of life in the intervention compared to the sham intervention group.
Between baseline and week 18.
Changes between baseline and week 18 on fatigue in the intervention compared to the sham intervention group.
Between baseline and week 18.
Changes between baseline and week 18 on quality of life in the intervention compared to the sham intervention group.
Between baseline and week 18.
Changes between baseline and week 18 on psychological outcomes in the intervention compared to the sham intervention group.
Between baseline and week 18.
Changes between week 12 and week 18 on goal attainment in the intervention compared to the sham intervention group.
Between week 12 and week 18.
- +7 more secondary outcomes
Other Outcomes (4)
Effect of personality
Between baseline and week 18.
Effect of demographics
Between baseline and week 18.
Effect of C-Coach
Between baseline and week 12.
- +1 more other outcomes
Study Arms (2)
Conscientiousness Coaching
EXPERIMENTALSham Intervention
SHAM COMPARATORInterventions
In this arm, participants complete the conscientiousness coaching before the cognitive rehabilitation. All participants (both arms) will receive 6 weeks of cognitive rehabilitation using BrainHQ (2 times per week, 1 hour each).
In this arm, participants complete the sham intervention before the cognitive rehabilitation. All participants (both arms) will receive 6 weeks of cognitive rehabilitation using BrainHQ (2 times per week, 1 hour each).
Eligibility Criteria
You may qualify if:
- Confirmed relapsing remitting or secondary progressive MS diagnosis according to the McDonald 2017 criteria
- Expanded Disability Status Scale (EDSS) score \< 7
- Relapse free period ≥ 3 months
- Age 18-65 years
- Language Dutch, English or German for each centre respectively
You may not qualify if:
- High conscientiousness, measured with a T score 65 or higher on the BFI-2 subscale for conscientiousness
- Current or prior brain trauma or neurological condition (other than MS)
- Psychiatric disorder that heavily impacts cognitive and/or daily functioning
- Medication intake and/or substance abuse that has an influence on cognitive functioning
- For Dutch subsample undergoing MRI: Contradiction for MRI
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universiteit Leidenlead
- Reha Rheinfeldencollaborator
- University at Buffalocollaborator
Study Sites (3)
Jacobs School of Medicine and Biomedical Sciences, Neurology, University at Buffalo
Buffalo, New York, 14203, United States
Health, Medical and Neuropsychology, Institute of Psychology, Faculty of Behvavioural and Social Siences, Leiden University
Leiden, 2333AK, Netherlands
Research Department, Reha Rheinfelden
Rheinfelden, 4310, Switzerland
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hanneke E Hulst, Prof
Leiden University
- PRINCIPAL INVESTIGATOR
Priska Zuber, PhD
Reha Rheinfelden
- PRINCIPAL INVESTIGATOR
Ralph HB Benedict, Prof
Jacobs School of Medicine and Biomedical Sciences, Neurology, University at Buffalo
- PRINCIPAL INVESTIGATOR
Marit FL Ruitenberg, PhD
Leiden University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
November 3, 2025
First Posted
November 10, 2025
Study Start
November 1, 2025
Primary Completion (Estimated)
December 31, 2028
Study Completion (Estimated)
December 31, 2028
Last Updated
November 10, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share